11
Views
2
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Mechanisms of anti-DNA antibody production

Pages 300-304 | Published online: 02 Jan 2014

References

  • Papadaki HA, Boumpas DT, Gibson FM, Jayne DR, Axford JS, Gordon-Smith EC, et al. Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 2001;115: 167–74.
  • Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685–92.
  • Hepburn AL. The LE cell. Ftheumatology 2001;40:826–7.
  • Mendlovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, et al. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci USA 1988;85:2260–4.
  • Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994;8:1296–301.
  • Satake F, Watanabe N, Miyasaka N, Kanai Y, Kubota T. Induction of anti-DNA antibodies by immunization with anti-DNA antibod-ies: mechanism and characterization. Lupus 2000;9:489–97.
  • Herkel J, Mimran A, Erez N, Kam N, Lohse AW, Märker-Hermann E, et al. Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibod-ies. J Autoimmun 2001;17: 63–9.
  • Herkel J, Erez-Alon N, Mimran A, Wolkowicz R, Harmelin A, Ruiz P, et al. Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA. Eur J Immunol 2000;30:977–84.
  • Kaliyaperumal A, Mohan C, Wu W, Datta SK. Nucleosomal pep-tide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med 1996;183:2459–69.
  • Lu L, Kaliyaperumal A, Boumpas DT, Datta SK. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J Clin Invest 1999;104:345–55.
  • Amoura Z, Koutouzov S, Piette JC. The role of nucleosomes in 22. lupus. Curr Opin Ftheumato1;2000:12: 369–73.
  • Hirata D, Iwamoto M, Yoshio T, Okazaki H, Masuyama J, Mimori A, et al. Nucleolin as the earliest target molecule of autoantibodies 23. produced in MRL/lpr lupus-prone mice. Clin Immunol 2000;97: 50–8.
  • Chimenti D, Marchini B, Manzini S, Bonbardieri S, Migliorini P. Induction of anti-DNA antibodies in preautoimmune NZB X 24. NZW Fl mice by immunization with a DNA-DNase I complex. J Autoimmun 2000;15: 9–13.
  • Desai DD, Marion TN. Induction of anti-DNA antibody with DNA-peptide complexes. Int Immunol 2000;12:1569-78.25.
  • Moens U, Mathiesen I, van Ghelue M, Rekvig OP. Green fluorescent protein modified to bind DNA initiates production of anti-DNA antibodies when expressed in vivo. Mol Immunol2001;38:505-14.26.
  • Cerutti ML, Centeno JM, Goldbaum FA, de Prat-Gay G. Genera-tion of sequence-specific, high affinity anti-DNA antibodies. J Biol 27. Chem 2001;276: 12769–73.
  • James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immuni-zation: Sm B/B' -derived PPPGMRPP and PPPGIRGP induce 28. spliceosome autoimmunity. J Exp Med 1995;181:453–61.
  • James JA, Harley JB. A model of peptide-induced lupus autoim-mune B cell epitope spreading is strain specific and is not H-2 29. restricted in mice. J Immunol 1998;160:502–8.
  • Arbuckle MR, Gross T, Scofield RH, Hinshaw LB, Chang ACK, Taylor FB Jr, et al. Lupus humoral autoimmunity induced in a 30. primate model by short peptide immunization. J Investig Med 1998;46: 58–65.
  • Wun HL, Leung DTM, Wong KC, Chui YL, Lim PL. Molecular 31. mimicry: anti-DNA antibodies may arise inadvertently as a re-sponse to antibodies generated to microorganisms. Int Immunol 2001;13: 1099–107.
  • Sharma A, Isenberg DA, Diamond B. Crossreactivity of human anti-dsDNA antibodies to phosphorylcholine: clues to their origin. J Autoimmun 2001;16:479–84.
  • Eivazova ER, McDonnell JM, Sutton BJ, Staines NA. Crossreactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus. Arthritis Rheum 2000;43:429.39.
  • Zack DJ, Yamamoto K, Wong AL, Stempniak M, French C, Weisbart RH. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus. J Immunol 1995;154:1987.94.
  • Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 1998;188:29.38.
  • DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189.93.
  • Bolton SJ, Perry VH. Histone H1: a neuronal protein that binds bacterial lipopolysaccharide. J Neurocytol 1997;26:823.31.
  • Mostoslavsky G, Fischel R, Yachimovich N, Yarkoni Y, Rosenmann E, Monestier M, et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 2001;31:1221.7.
  • Deocharan B, Qing X, Lichauco J, Putterman C. -actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 2002;168:3072.8.
  • Bynoe MS, Grimaldi CM, Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci USA 2000;97: 2703.8.
  • Peeva E, Grimaldi C, Spatz L, Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest 2000;106:1373.9.
  • Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Munoz J, Miranda JM, Jara LJ. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebocontrolled study. Lupus 1998;7:414.9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.